147 related articles for article (PubMed ID: 25967272)
1. Changes to Initial Postexposure Prophylaxis Regimens Between the Emergency Department and Clinic.
Bogoch II; Siemieniuk RA; Andrews JR; Scully EP; Mayer KH; Bell CM; Zachary KC; Yawetz S
J Acquir Immune Defic Syndr; 2015 Aug; 69(5):e182-4. PubMed ID: 25967272
[No Abstract] [Full Text] [Related]
2. Patient attrition between the emergency department and clinic among individuals presenting for HIV nonoccupational postexposure prophylaxis.
Bogoch II; Scully EP; Zachary KC; Yawetz S; Mayer KH; Bell CM; Andrews JR
Clin Infect Dis; 2014 Jun; 58(11):1618-24. PubMed ID: 24723288
[TBL] [Abstract][Full Text] [Related]
3. Commentary.
Liang SY; Adalja AA
Ann Emerg Med; 2016 Sep; 68(3):338-9. PubMed ID: 27568418
[No Abstract] [Full Text] [Related]
4. Nonoccupational HIV post-exposure prophylaxis: a 10-year retrospective analysis.
Tissot F; Erard V; Dang T; Cavassini M
HIV Med; 2010 Oct; 11(9):584-92. PubMed ID: 20345883
[TBL] [Abstract][Full Text] [Related]
5. Updated US Public Health Service guidelines for the management of occupational exposures to human immunodeficiency virus and recommendations for postexposure prophylaxis.
Kuhar DT; Henderson DK; Struble KA; Heneine W; Thomas V; Cheever LW; Gomaa A; Panlilio AL;
Infect Control Hosp Epidemiol; 2013 Sep; 34(9):875-92. PubMed ID: 23917901
[TBL] [Abstract][Full Text] [Related]
6. HIV Prevention and Treatment: The Evolving Role of the Emergency Department.
Stanley K; Lora M; Merjavy S; Chang J; Arora S; Menchine M; Jacobson KR
Ann Emerg Med; 2017 Oct; 70(4):562-572.e3. PubMed ID: 28347557
[TBL] [Abstract][Full Text] [Related]
7. Canadian guideline on HIV pre-exposure prophylaxis and nonoccupational postexposure prophylaxis.
Tan DHS; Hull MW; Yoong D; Tremblay C; O'Byrne P; Thomas R; Kille J; Baril JG; Cox J; Giguere P; Harris M; Hughes C; MacPherson P; O'Donnell S; Reimer J; Singh A; Barrett L; Bogoch I; Jollimore J; Lambert G; Lebouche B; Metz G; Rogers T; Shafran S;
CMAJ; 2017 Nov; 189(47):E1448-E1458. PubMed ID: 29180384
[No Abstract] [Full Text] [Related]
8. Optimal HIV Postexposure Prophylaxis Regimen Completion With Single Tablet Daily Elvitegravir/Cobicistat/Tenofovir Disoproxil Fumarate/Emtricitabine Compared With More Frequent Dosing Regimens.
Mayer KH; Jones D; Oldenburg C; Jain S; Gelman M; Zaslow S; Grasso C; Mimiaga MJ
J Acquir Immune Defic Syndr; 2017 Aug; 75(5):535-539. PubMed ID: 28696345
[TBL] [Abstract][Full Text] [Related]
9. Clinical practice. Postexposure prophylaxis for HIV infection.
Landovitz RJ; Currier JS
N Engl J Med; 2009 Oct; 361(18):1768-75. PubMed ID: 19864675
[No Abstract] [Full Text] [Related]
10. Postexposure prophylaxis for HIV infection.
Nwokolo NC; Hawkins DA
AIDS Read; 2001 Aug; 11(8):402-12. PubMed ID: 11570266
[TBL] [Abstract][Full Text] [Related]
11. HIV seroconversion in a health care worker who underwent postexposure prophylaxis following needlestick injury.
Borba Brum MC; Dantas Filho FF; Yates ZB; Verçoza Viana MC; Martin Chaves EB; Trindade DM
Am J Infect Control; 2013 May; 41(5):471-2. PubMed ID: 23084562
[No Abstract] [Full Text] [Related]
12. Comparison of two HIV postexposure prophylaxis regimens among men who have sex with men in Amsterdam: adverse effects do not influence compliance.
Sonder GJ; Prins JM; Regez RM; Brinkman K; Mulder JW; Veenstra J; Claessen FA; van den Hoek A
Sex Transm Dis; 2010 Nov; 37(11):681-6. PubMed ID: 20644499
[TBL] [Abstract][Full Text] [Related]
13. Postexposure prophylaxis against human immunodeficiency virus.
Tolle MA; Schwarzwald HL
Am Fam Physician; 2010 Jul; 82(2):161-6. PubMed ID: 20642270
[TBL] [Abstract][Full Text] [Related]
14. The Transition From Postexposure Prophylaxis to Preexposure Prophylaxis: An Emerging Opportunity for Biobehavioral HIV Prevention.
Jain S; Krakower DS; Mayer KH
Clin Infect Dis; 2015 Jun; 60 Suppl 3(Suppl 3):S200-4. PubMed ID: 25972505
[TBL] [Abstract][Full Text] [Related]
15. [HIV post-exposure prevention. Minutes are important--therefore PEP (postexposure prophylaxis) emergency set].
MMW Fortschr Med; 2000; 142(3 Suppl):10. PubMed ID: 10893950
[No Abstract] [Full Text] [Related]
16. Most common prescribing error in postexposure prophylaxis of HIV/AIDS.
Mahajan A; Sharma H; Bhagat A; Tandon VR; Sharma R; Sharma S
J Assoc Physicians India; 2007 Mar; 55():246-7. PubMed ID: 17598343
[No Abstract] [Full Text] [Related]
17. Tolerability of two different combinations of antiretroviral drugs including tenofovir used in occupational and nonoccupational postexposure prophylaxis for HIV.
Burty C; Prazuck T; Truchetet F; Christian B; Penalba C; Salmon-Ceron D; Yazdanpanah Y; May T; Rabaud C
AIDS Patient Care STDS; 2010 Jan; 24(1):1-3. PubMed ID: 20095911
[No Abstract] [Full Text] [Related]
18. Adverse effects associated with use of nevirapine in HIV postexposure prophylaxis for 2 health care workers.
Johnson S; Baraboutis JG
JAMA; 2000 Dec; 284(21):2722-3. PubMed ID: 11105175
[No Abstract] [Full Text] [Related]
19. [Post-exposure prophylaxis of HIV infection. German-Austrian recommendations, update September 2007].
;
Dtsch Med Wochenschr; 2009 Jan; 134 Suppl 1():S16-33. PubMed ID: 19172552
[No Abstract] [Full Text] [Related]
20. Tenofovir disoproxil fumarate-induced Fanconi's syndrome during HIV postexposure prophylaxis.
Penot P; Gosset C; Verine J; Molina JM
AIDS; 2016 May; 30(8):1311-3. PubMed ID: 27128332
[No Abstract] [Full Text] [Related]
[Next] [New Search]
